Acne Medication Market

Acne Medication Market Size By Therapeutic Class (Antibiotics, Benzoyl Peroxide, Retinoids, Salicylic Acid, and Others), and By Type (Over-The-Counter Medicines and Prescription Medicines) Regions, Global Industry Analysis, Share, Growth, Trends, and Forecast 2023 to 2032

Base Year: 2022 Historical Data: 2019-21
  • Report ID: TBI-13845
  • Published Date: Dec, 2023
  • Pages: 239
  • Category: Healthcare
  • Format: PDF
Buy @ $4700.00 Request Sample PDF

The global acne medication market was valued at USD 12.3 billion in 2022, growing at a CAGR of 4.2% from 2023 to 2032. The market is expected to reach USD 18.5 billion by 2032. The rising incidence of acne and the increasing need for safe and efficient acne treatments drive significant growth in the global market for acne medications. Furthermore, it is anticipated that rising research and development and public knowledge of the range of treatment choices available will fuel market expansion.

Market Introduction:

One of the most prevalent skin disorders is acne, or acne vulgaris, which is mostly brought on by structural alterations in the skin. It has an impact on millions of teenagers worldwide. Scarring, greasy skin, blackheads, and zits are its hallmarks. There are two varieties of acne: non-inflammatory and inflammatory. The latter can leave persistent damage on the skin and recover more slowly. Typically, it affects areas of skin like the upper chest, back, and face with a relatively high concentration of sweat glands. Drugs prescribed to treat acne are known as acne medicines. These include several over-the-counter and prescription medications such as benzoyl peroxide, antibiotics, salicylic acid, retinoids, and isotretinoin, as well as oral contraceptives.

Acne Medication Market Size

Get an overview of this study by requesting a free sample

Recent Development

In March 2022, Galderma introduced TWYNEO Cream to the U.S. market to address facial acne at the American Academy of Dermatology Annual Meeting. The product will go on sale in the spring. 

In January 2022, Journey Medical Corporation purchased the Stabilising Technology (MST) Franchise and two topical minocycline medicines approved by the Food and Drug Administration from VYNE Therapeutics, Inc. AMZEEQ is a product in this series that treats acne. 

In January 2022, Following federal authorities in the United States granting antitrust clearance, Galderma S.A. completed the acquisition of ALASTIN Skincare, Inc. Demand for high-quality goods has increased due to growing consumer interest and the growing acceptance of aesthetic skin care procedures.

Market Dynamics:

Drivers

Growing acne breakouts-  The rising incidence of acne worldwide is one of the main factors anticipated to support the growth of the global market for acne treatments over the projected period. For example, a skin disorder known as acne arises when oil and dead skin cells clog hair follicles. Even though it affects people of all ages, teenagers are most likely to experience it. Acne is one of the most common diseases in the world, affecting around 9.4% of the population, according to the National Institutes of Health (NIH). The demand for safe and effective acne treatments rises, propelling the growth of the worldwide acne medications market.

Restraints:

Increasing demand for generics- One of the primary factors anticipated to impede the expansion of the worldwide acne medications market is the growing need for or acceptance of generic medications. There are a few instances where generic versions of trademarked products are sold on the market, even while branded ones are not. For example, isotretinoin is still accessible in a generic form but is no longer sold under the Accutane name. Customers choose generic medications over branded ones because they are less expensive than their branded counterparts, which limits the market's expansion.

Opportunities:

Growing clinical approvals- Acne is becoming more common in adults and teens, which has drawn the attention of manufacturers and increased demand for acne drugs. The problem of successfully and safely treating acne is the main focus of drug research. For example, the FDA in the United States has approved the new abbreviated drug application for topical retinoid adapalene gel USP 0.3%, which is made by Alembic Pharmaceuticals and is intended to treat acne vulgaris. Comparably, Zydus Lifesciences was granted FDA permission in June 2022 to market Adapalene with Benzoyl Peroxide topical gel in the United States. Acne is treated using this generic medication.

Regional segmentation analysis:

The regions analyzed for the market include North America, Europe, South America, Asia Pacific, the Middle East, and Africa. North America emerged as the largest global acne medication market, with a 41.4% market revenue share in 2022.

The region's dominance can be attributed to the rising rates of acne in the area as well as the growing concerns of the populace about appearance. As a result, big businesses are launching novel medications on the North American market. For example, Sun Pharma introduced Winlevi, a cream, to the United States in November 2021 to treat the ailment. A large increase in the patient population, rising public awareness of cutting-edge therapies, and the existence of well-known brands all had a role in the high demand for the items that made the region the world leader in that particular field.

North America Region Acne Medication Market Share in 2022 - 41.4%

 

www.thebrainyinsights.com

Check the geographical analysis of this market by requesting a free sample

Therapeutic Class Segment Analysis

The therapeutic class segment is divided into antibiotics, benzoyl peroxide, retinoids, salicylic acid, and others. The retinoids segment dominated the market, with a market share of around 29% in 2022. Because they unclog pores, retinoids are best used for moderate to severe acne, improving the efficacy of topical creams and gels. Furthermore, retinoids limit the development of fresh pimples on the skin while also reducing post-inflammatory hyperpigmentation.

Type Segment Analysis

The type segment is divided into over-the-counter medicines and prescription medicines. The prescription medicines segment dominated the market, with a market share of around 57% in 2022. Benzoyl peroxide or a topical retinoid are frequently coupled with prescription acne medications, such as antibiotics, to provide an efficient combination expected to propel the prescription acne medication market throughout the forecast period.

Some of the Key Market Players:
  • Galderma S.A.
  • Bausch Health
  • Bayer AG
  • Paratek Pharmaceuticals
  • Akorn Operating, LLC
  • Pfizer, Inc.
  • Mayne Pharmaceuticals
  • Allergan (AbbVie)
  • Reckitt Benckiser Group plc
  • Stiefel Laboratories (GlaxoSmithKline plc)
  • Almirall S.A.
  • Teva Pharmaceutical Industries
  • Sun Pharmaceutical Industries Ltd.
  • Procter & Gamble
  • Viatris

Report Description:

Attribute Description
Market Size Revenue (USD Billion)
Market size value in 2022 USD 12.3 Billion
Market size value in 2032 USD 18.5 Billion
CAGR (2023 to 2032) 4.2%
Historical data 2019-2021
Base Year 2022
Forecast 2023-2032
Region The regions analyzed for the market are Asia Pacific, Europe, South America, North America, and Middle East & Africa. Furthermore, the regions are further analyzed at the country level.
Segments Therapeutic Class, Type

Frequesntly Asked Questions

As per The Brainy Insights, the size of the acne medication market was valued at USD 12.3 billion in 2022 to USD 18.5 billion by 2032.

The global acne medication market is growing at a CAGR of 4.2% during the forecast period 2023-2032.

North America emerged as the largest acne medication market.

1. Introduction
    1.1. Objectives of the Study
    1.2. Market Definition
    1.3. Research Scope
    1.4. Currency
    1.5. Key Target Audience

2. Research Methodology and Assumptions

3. Executive Summary

4. Premium Insights
    4.1. Porter’s Five Forces Analysis
    4.2. Value Chain Analysis
    4.3. Top Investment Pockets
          4.3.1. Market Attractiveness Analysis by Therapeutic Class
          4.3.2. Market Attractiveness Analysis by Type
          4.3.3. Market Attractiveness Analysis by Region
    4.4. Industry Trends

5. Market Dynamics
    5.1. Market Evaluation
    5.2. Drivers
          5.2.1. Growing acne breakouts
    5.3. Restraints
          5.3.1. Side effects of medicines
    5.4. Opportunities
          5.4.1. Growing clinical approvals
    5.5. Challenges
          5.5.1. Increasing adoption of generic drugs

6. Global Acne Medication Market Analysis and Forecast, By Therapeutic Class
    6.1. Segment Overview
    6.2. Antibiotics
    6.3. Benzoyl Peroxide
    6.4. Retinoids
    6.5. Salicylic Acid
    6.6. Others

7. Global Acne Medication Market Analysis and Forecast, By Type
    7.1. Segment Overview
    7.2. Over-The-Counter Medicines
    7.3. Prescription Medicines

8. Global Acne Medication Market Analysis and Forecast, By Regional Analysis
    8.1. Segment Overview
    8.2. North America
          8.2.1. U.S.
          8.2.2. Canada
          8.2.3. Mexico
    8.3. Europe
          8.3.1. Germany
          8.3.2. France
          8.3.3. U.K.
          8.3.4. Italy
          8.3.5. Spain
    8.4. Asia-Pacific
          8.4.1. Japan
          8.4.2. China
          8.4.3. India
    8.5. South America
          8.5.1. Brazil
    8.6. Middle East and Africa
          8.6.1. UAE
          8.6.2. South Africa

9. Global Acne Medication Market-Competitive Landscape
    9.1. Overview
    9.2. Market Share of Key Players in Global Acne Medication Market
          9.2.1. Global Company Market Share
          9.2.2. North America Company Market Share
          9.2.3. Europe Company Market Share
          9.2.4. APAC Company Market Share
    9.3. Competitive Situations and Trends
          9.3.1. Product Launches and Developments
          9.3.2. Partnerships, Collaborations, and Agreements
          9.3.3. Mergers & Acquisitions
          9.3.4. Expansions

10. Company Profiles
    10.1. Galderma S.A.
          10.1.1. Business Overview
          10.1.2. Company Snapshot
          10.1.3. Company Market Share Analysis
          10.1.4. Company Product Portfolio
          10.1.5. Recent Developments
          10.1.6. SWOT Analysis
    10.2. Bausch Health
          10.2.1. Business Overview
          10.2.2. Company Snapshot
          10.2.3. Company Market Share Analysis
          10.2.4. Company Product Portfolio
          10.2.5. Recent Developments
          10.2.6. SWOT Analysis
    10.3. Bayer AG
          10.3.1. Business Overview
          10.3.2. Company Snapshot
          10.3.3. Company Market Share Analysis
          10.3.4. Company Product Portfolio
          10.3.5. Recent Developments
          10.3.6. SWOT Analysis
    10.4. Paratek Pharmaceuticals
          10.4.1. Business Overview
          10.4.2. Company Snapshot
          10.4.3. Company Market Share Analysis
          10.4.4. Company Product Portfolio
          10.4.5. Recent Developments
          10.4.6. SWOT Analysis
    10.5. Akorn Operating, LLC
          10.5.1. Business Overview
          10.5.2. Company Snapshot
          10.5.3. Company Market Share Analysis
          10.5.4. Company Product Portfolio
          10.5.5. Recent Developments
          10.5.6. SWOT Analysis
    10.6. Pfizer, Inc.
          10.6.1. Business Overview
          10.6.2. Company Snapshot
          10.6.3. Company Market Share Analysis
          10.6.4. Company Product Portfolio
          10.6.5. Recent Developments
          10.6.6. SWOT Analysis
    10.7. Mayne Pharmaceuticals
          10.7.1. Business Overview
          10.7.2. Company Snapshot
          10.7.3. Company Market Share Analysis
          10.7.4. Company Product Portfolio
          10.7.5. Recent Developments
          10.7.6. SWOT Analysis
    10.8. Allergan (AbbVie)
          10.8.1. Business Overview
          10.8.2. Company Snapshot
          10.8.3. Company Market Share Analysis
          10.8.4. Company Product Portfolio
          10.8.5. Recent Developments
          10.8.6. SWOT Analysis
    10.9. Reckitt Benckiser Group plc
          10.9.1. Business Overview
          10.9.2. Company Snapshot
          10.9.3. Company Market Share Analysis
          10.9.4. Company Product Portfolio
          10.9.5. Recent Developments
          10.9.6. SWOT Analysis
    10.10. Stiefel Laboratories (GlaxoSmithKline plc)
          10.10.1. Business Overview
          10.10.2. Company Snapshot
          10.10.3. Company Market Share Analysis
          10.10.4. Company Product Portfolio
          10.10.5. Recent Developments
          10.10.6. SWOT Analysis
    10.11. Almirall S.A.
          10.11.1. Business Overview
          10.11.2. Company Snapshot
          10.11.3. Company Market Share Analysis
          10.11.4. Company Product Portfolio
          10.11.5. Recent Developments
          10.11.6. SWOT Analysis
    10.12. Teva Pharmaceutical Industries
          10.12.1. Business Overview
          10.12.2. Company Snapshot
          10.12.3. Company Market Share Analysis
          10.12.4. Company Product Portfolio
          10.12.5. Recent Developments
          10.12.6. SWOT Analysis
    10.13. Sun Pharmaceutical Industries Ltd.
          10.13.1. Business Overview
          10.13.2. Company Snapshot
          10.13.3. Company Market Share Analysis
          10.13.4. Company Product Portfolio
          10.13.5. Recent Developments
          10.13.6. SWOT Analysis
    10.14. Procter & Gamble
          10.14.1. Business Overview
          10.14.2. Company Snapshot
          10.14.3. Company Market Share Analysis
          10.14.4. Company Product Portfolio
          10.14.5. Recent Developments
          10.14.6. SWOT Analysis
    10.15. Viatris
          10.15.1. Business Overview
          10.15.2. Company Snapshot
          10.15.3. Company Market Share Analysis
          10.15.4. Company Product Portfolio
          10.15.5. Recent Developments
          10.15.6. SWOT Analysis
 

List of Table

1. Global Acne Medication Market, By Therapeutic Class, 2019-2032 (USD Billion)

2. Global Antibiotics, Acne Medication Market, By Region, 2019-2032 (USD Billion) 

3. Global Benzoyl Peroxide, Acne Medication Market, By Region, 2019-2032 (USD Billion) 

4. Global Retinoids, Acne Medication Market, By Region, 2019-2032 (USD Billion) 

5. Global Salicylic Acid, Acne Medication Market, By Region, 2019-2032 (USD Billion)

6. Global Others, Acne Medication Market, By Region, 2019-2032 (USD Billion)

7. Global Acne Medication Market, By Type, 2019-2032 (USD Billion)

8. Global Over-The-Counter Medicines, Acne Medication Market, By Region, 2019-2032 (USD Billion)

9. Global Prescription Medicines, Acne Medication Market, By Region, 2019-2032 (USD Billion)

10. North America Acne Medication Market, By Therapeutic Class, 2019-2032 (USD Billion)

11. North America Acne Medication Market, By Type, 2019-2032 (USD Billion)

12. U.S. Acne Medication Market, By Therapeutic Class, 2019-2032 (USD Billion)

13. U.S. Acne Medication Market, By Type, 2019-2032 (USD Billion)

14. Canada Acne Medication Market, By Therapeutic Class, 2019-2032 (USD Billion)

15. Canada Acne Medication Market, By Type, 2019-2032 (USD Billion)

16. Mexico Acne Medication Market, By Therapeutic Class, 2019-2032 (USD Billion)

17. Mexico Acne Medication Market, By Type, 2019-2032 (USD Billion)

18. Europe Acne Medication Market, By Therapeutic Class, 2019-2032 (USD Billion)

19. Europe Acne Medication Market, By Type, 2019-2032 (USD Billion)

20. Germany Acne Medication Market, By Therapeutic Class, 2019-2032 (USD Billion)

21. Germany Acne Medication Market, By Type, 2019-2032 (USD Billion)

22. France Acne Medication Market, By Therapeutic Class, 2019-2032 (USD Billion)

23. France Acne Medication Market, By Type, 2019-2032 (USD Billion)

24. U.K. Acne Medication Market, By Therapeutic Class, 2019-2032 (USD Billion)

25. U.K. Acne Medication Market, By Type, 2019-2032 (USD Billion)

26. Italy Acne Medication Market, By Therapeutic Class, 2019-2032 (USD Billion)

27. Italy Acne Medication Market, By Type, 2019-2032 (USD Billion)

28. Spain Acne Medication Market, By Therapeutic Class, 2019-2032 (USD Billion)

29. Spain Acne Medication Market, By Type, 2019-2032 (USD Billion)

30. Asia Pacific Acne Medication Market, By Therapeutic Class, 2019-2032 (USD Billion)

31. Asia Pacific Acne Medication Market, By Type, 2019-2032 (USD Billion)

32. Japan Acne Medication Market, By Therapeutic Class, 2019-2032 (USD Billion)

33. Japan Acne Medication Market, By Type, 2019-2032 (USD Billion)

34. China Acne Medication Market, By Therapeutic Class, 2019-2032 (USD Billion)

35. China Acne Medication Market, By Type, 2019-2032 (USD Billion)

36. India Acne Medication Market, By Therapeutic Class, 2019-2032 (USD Billion)

37. India Acne Medication Market, By Type, 2019-2032 (USD Billion)

38. South America Acne Medication Market, By Therapeutic Class, 2019-2032 (USD Billion)

39. South America Acne Medication Market, By Type, 2019-2032 (USD Billion)

40. Brazil Acne Medication Market, By Therapeutic Class, 2019-2032 (USD Billion)

41. Brazil Acne Medication Market, By Type, 2019-2032 (USD Billion)

42. Middle East and Africa Acne Medication Market, By Therapeutic Class, 2019-2032 (USD Billion)

43. Middle East and Africa Acne Medication Market, By Type, 2019-2032 (USD Billion)

44. UAE Acne Medication Market, By Therapeutic Class, 2019-2032 (USD Billion)

45. UAE Acne Medication Market, By Type, 2019-2032 (USD Billion)

46. South Africa Acne Medication Market, By Therapeutic Class, 2019-2032 (USD Billion)

47. South Africa Acne Medication Market, By Type, 2019-2032 (USD Billion)

List of Figures 

1. Global Acne Medication Market Segmentation

2. Global Acne Medication Market: Research Methodology

3. Market Size Estimation Methodology: Bottom-Up Approach

4. Market Size Estimation Methodology: Top-Down Approach

5. Data Triangulation

6. Porter’s Five Forces Analysis 

7. Value Chain Analysis 

8. Global Acne Medication Market Attractiveness Analysis by Therapeutic Class

9. Global Acne Medication Market Attractiveness Analysis by Type

10. Global Acne Medication Market Attractiveness Analysis by Region

11. Global Acne Medication Market: Dynamics

12. Global Acne Medication Market Share by Therapeutic Class (2023 & 2032)

13. Global Acne Medication Market Share by Type (2023 & 2032)

14. Global Acne Medication Market Share by Regions (2023 & 2032)

15. Global Acne Medication Market Share by Company (2022)

This study forecasts global, regional, and country revenue from 2019 to 2032. The Brainy Insights has segmented the global acne medication market based on the below-mentioned segments:

Global Acne Medication Market By Therapeutic Class:

  • Antibiotics
  • Benzoyl Peroxide
  • Retinoids
  • Salicylic Acid
  • Others  

Global Acne Medication Market By Type:

  • Over-The-Counter Medicines
  • Prescription Medicines  

Global Acne Medication Market By Region:                               

  • North America
    • U.S.
    • Canada
    • Mexico
  • Europe
    • Germany
    • France
    • U.K.
    • Italy
    • Spain
  • Asia-Pacific
    • Japan
    • China
    • India
  • South America
    • Brazil
  • Middle East and Africa  
    • UAE
    • South Africa

Methodology

Research has its special purpose to undertake marketing efficiently. In this competitive scenario, businesses need information across all industry verticals; the information about customer wants, market demand, competition, industry trends, distribution channels etc. This information needs to be updated regularly because businesses operate in a dynamic environment. Our organization, The Brainy Insights incorporates scientific and systematic research procedures in order to get proper market insights and industry analysis for overall business success. The analysis consists of studying the market from a miniscule level wherein we implement statistical tools which helps us in examining the data with accuracy and precision. 

Our research reports feature both; quantitative and qualitative aspects for any market. Qualitative information for any market research process are fundamental because they reveal the customer needs and wants, usage and consumption for any product/service related to a specific industry. This in turn aids the marketers/investors in knowing certain perceptions of the customers. Qualitative research can enlighten about the different product concepts and designs along with unique service offering that in turn, helps define marketing problems and generate opportunities. On the other hand, quantitative research engages with the data collection process through interviews, e-mail interactions, surveys and pilot studies. Quantitative aspects for the market research are useful to validate the hypotheses generated during qualitative research method, explore empirical patterns in the data with the help of statistical tools, and finally make the market estimations.

The Brainy Insights offers comprehensive research and analysis, based on a wide assortment of factual insights gained through interviews with CXOs and global experts and secondary data from reliable sources. Our analysts and industry specialist assume vital roles in building up statistical tools and analysis models, which are used to analyse the data and arrive at accurate insights with exceedingly informative research discoveries. The data provided by our organization have proven precious to a diverse range of companies, facilitating them to address issues such as determining which products/services are the most appealing, whether or not customers use the product in the manner anticipated, the purchasing intentions of the market and many others.

Our research methodology encompasses an idyllic combination of primary and secondary initiatives. Key phases involved in this process are listed below:

MARKET RESEARCH PROCESS

Data Procurement:

The phase involves the gathering and collecting of market data and its related information with the help of different sources & research procedures.

The data procurement stage involves in data gathering and collecting through various data sources.

This stage involves in extensive research. These data sources includes:

Purchased Database: Purchased databases play a crucial role in estimating the market sizes irrespective of the domain. Our purchased database includes:

  • The organizational databases such as D&B Hoovers, and Bloomberg that helps us to identify the competitive scenario of the key market players/organizations along with the financial information.
  • Industry/Market databases such as Statista, and Factiva provides market/industry insights and deduce certain formulations. 
  • We also have contractual agreements with various reputed data providers and third party vendors who provide information which are not limited to:
    • Import & Export Data
    • Business Trade Information
    • Usage rates of a particular product/service on certain demographics mainly focusing on the unmet prerequisites

Primary Research: The Brainy Insights interacts with leading companies and experts of the concerned domain to develop the analyst team’s market understanding and expertise. It improves and substantiates every single data presented in the market reports. Primary research mainly involves in telephonic interviews, E-mail interactions and face-to-face interviews with the raw material providers, manufacturers/producers, distributors, & independent consultants. The interviews that we conduct provides valuable data on market size and industry growth trends prevailing in the market. Our organization also conducts surveys with the various industry experts in order to gain overall insights of the industry/market. For instance, in healthcare industry we conduct surveys with the pharmacists, doctors, surgeons and nurses in order to gain insights and key information of a medical product/device/equipment which the customers are going to usage. Surveys are conducted in the form of questionnaire designed by our own analyst team. Surveys plays an important role in primary research because surveys helps us to identify the key target audiences of the market. Additionally, surveys helps to identify the key target audience engaged with the market. Our survey team conducts the survey by targeting the key audience, thus gaining insights from them. Based on the perspectives of the customers, this information is utilized to formulate market strategies. Moreover, market surveys helps us to understand the current competitive situation of the industry. To be precise, our survey process typically involve with the 360 analysis of the market. This analytical process begins by identifying the prospective customers for a product or service related to the market/industry to obtain data on how a product/service could fit into customers’ lives.

Secondary Research: The secondary data sources includes information published by the on-profit organizations such as World bank, WHO, company fillings, investor presentations, annual reports, national government documents, statistical databases, blogs, articles, white papers and others. From the annual report, we analyse a company’s revenue to understand the key segment and market share of that organization in a particular region. We analyse the company websites and adopt the product mapping technique which is important for deriving the segment revenue. In the product mapping method, we select and categorize the products offered by the companies catering to domain specific market, deduce the product revenue for each of the companies so as to get overall estimation of the market size. We also source data and analyses trends based on information received from supply side and demand side intermediaries in the value chain. The supply side denotes the data gathered from supplier, distributor, wholesaler and the demand side illustrates the data gathered from the end customers for respective market domain.

The supply side for a domain specific market is analysed by:

  • Estimating and projecting penetration rates through analysing product attributes, availability of internal and external substitutes, followed by pricing analysis of the product.
  • Experiential assessment of year-on-year sales of the product by conducting interviews.

The demand side for the market is estimated through:

  • Evaluating the penetration level and usage rates of the product.
  • Referring to the historical data to determine the growth rate and evaluate the industry trends

In-house Library: Apart from these third-party sources, we have our in-house library of qualitative and quantitative information. Our in-house database includes market data for various industry and domains. These data are updated on regular basis as per the changing market scenario. Our library includes, historic databases, internal audit reports and archives.

Sometimes there are instances where there is no metadata or raw data available for any domain specific market. For those cases, we use our expertise to forecast and estimate the market size in order to generate comprehensive data sets. Our analyst team adopt a robust research technique in order to produce the estimates:

  • Applying demographic along with psychographic segmentation for market evaluation
  • Determining the Micro and Macro-economic indicators for each region 
  • Examining the industry indicators prevailing in the market. 

Data Synthesis: This stage involves the analysis & mapping of all the information obtained from the previous step. It also involves in scrutinizing the data for any discrepancy observed while data gathering related to the market. The data is collected with consideration to the heterogeneity of sources. Robust scientific techniques are in place for synthesizing disparate data sets and provide the essential contextual information that can orient market strategies. The Brainy Insights has extensive experience in data synthesis where the data passes through various stages:

  • Data Screening: Data screening is the process of scrutinising data/information collected from primary research for errors and amending those collected data before data integration method. The screening involves in examining raw data, identifying errors and dealing with missing data. The purpose of the data screening is to ensure data is correctly entered or not. The Brainy Insights employs objective and systematic data screening grades involving repeated cycles of quality checks, screening and suspect analysis.
  • Data Integration: Integrating multiple data streams is necessary to produce research studies that provide in-depth picture to the clients. These data streams come from multiple research studies and our in house database. After screening of the data, our analysts conduct creative integration of data sets, optimizing connections between integrated surveys and syndicated data sources. There are mainly 2 research approaches that we follow in order to integrate our data; top down approach and bottom up approach.

Market Deduction & Formulation: The final stage comprises of assigning data points at appropriate market spaces so as to deduce feasible conclusions. Analyst perspective & subject matter expert based holistic form of market sizing coupled with industry analysis also plays a crucial role in this stage.

This stage involves in finalization of the market size and numbers that we have collected from data integration step. With data interpolation, it is made sure that there is no gap in the market data. Successful trend analysis is done by our analysts using extrapolation techniques, which provide the best possible forecasts for the market.

Data Validation & Market Feedback: Validation is the most important step in the process. Validation & re-validation via an intricately designed process helps us finalize data-points to be used for final calculations.

The Brainy Insights interacts with leading companies and experts of the concerned domain to develop the analyst team’s market understanding and expertise. It improves and substantiates every single data presented in the market reports. The data validation interview and discussion panels are typically composed of the most experienced industry members. The participants include, however, are not limited to:

  • CXOs and VPs of leading companies’ specific to sector
  • Purchasing managers, technical personnel, end-users
  • Key opinion leaders such as investment bankers, and industry consultants

Moreover, we always validate our data and findings through primary respondents from all the major regions we are working on.

Some Facts About The Brainy Insights

50%

Free Customization

300+

Fortune 500 Clients

1

Free Yearly Update On Purchase Of Multi/Corporate License

900+

Companies Served Till Date